Selected a new drug development program including government grant (₩600M) from National Research Foundation of Korea. This program will enable AevisBio to further develop the TPD platform technologies. AevisBio will open the Chemical Research Center at Institut Pasteur Korea in Pangyo, Korea, through this program.